(“Avant” or the“Company”) and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence ...

Presentation highlights include 48-month data from the OAKS and DERBY trials as well as the GALE open-label extension.

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to ...

Zilia, a Quebec City-based medical technology company, has received Health Canada’s approval of its flagship product, the ...

In summary, type 2 diabetes can have a big impact on your eyesight, but much of the damage can be prevented with regular ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a ...

Recognize these 6 crucial early warning signs of diabetic eye disease before permanent vision damage occurs. Learn what ...

The eye test would be another tool for early diagnosis of degenerative brain diseases. A blood test that assists with early ...

It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry ...